Recruiting Systemic Mastocytosis Studies in Palo Alto
About Systemic Mastocytosis Clinical Trials in Palo Alto
Systemic mastocytosis is a rare condition caused by accumulation of abnormal mast cells in the bone marrow, skin, liver, spleen, and GI tract. It can cause allergic reactions, bone pain, and organ damage. Treatment includes targeted therapies, antihistamines, and mast cell stabilizers.
There are currently 1 systemic mastocytosis clinical trials recruiting participants in Palo Alto, CALIFORNIA. These studies are seeking a combined 534 participants. Research is being sponsored by Blueprint Medicines Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Systemic Mastocytosis Clinical Trials in Palo Alto — FAQ
Are there systemic mastocytosis clinical trials in Palo Alto?
Yes, there are 1 systemic mastocytosis clinical trials currently recruiting in Palo Alto, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What systemic mastocytosis treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for systemic mastocytosis.
Data updated March 2, 2026 from ClinicalTrials.gov